Genspeed Biotech GmbH
Currently, nine highly qualified employees are devoted to the development, production and sales of in-vitro diagnostics for the rapid identification of various pathogens.
Under the umbrella of Greiner Bio-One the basic technology of Genspeed® was developed and finalized to become a CE-certified IVD platform.
With its novel combination of microfluidics, miniaturised opto-electronics and automation Genspeed® enables the simultaneous detection of multiple analytes at the point of care within a few minutes.
Genspeed® may be used for nucleic acid-based genetic testing as well as for protein analyses. Thus, the platform facilitates the rapid identification of defined bacteria or viruses as well as the quantitation of certain biomarkers in blood or other biological material.
- Genspeed® HAI, a product line for the rapid detection of the most common nosocomial pathogens and their resistances. An indispensable tool for an efficient, sustainable and responsible patient care.
- PerioPOC®, an assay for the differential diagnostics within the dental office for an individual therapeutic approach and efficient monitoring.
- Genspeed®, a universal Point of Care Testing (POCT) technology for assay manufacturers who aim for a maximum benefit through fast and reliable near-patient testing.
The Genspeed® Technology allows easy and fast detection of pathogens or biomarkers at the point of care.
Your career with Genspeed
If you want to contact us directly feel free to send an email to email@example.com.
We currently don't have any jobs.